Sialylation of anti-histone immunoglobulin G autoantibodies determines their capabilities to participate in the clearance of late apoptotic cells

Clinical and Experimental Immunology

Volumn 184, Issue 1, 2016, Pages 110-117

  Magorivska, I ^a,b   Munoz L E ^a   Janko, C ^a   Dumych, T ^b   Rech, J ^a   Schett, G ^a   Nimmerjahn, F ^a   Bilyy, R ^a,b   Herrmann, M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b INSTITUTE OF CELL BIOLOGY   (Ukraine)

Author keywords

Autoantibodies; IgG; Lectin; Sialylation; SLE

Indexed keywords

HISTONE ANTIBODY; HISTONE IMMUOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTOANTIBODY; HISTONE; IL6 PROTEIN, HUMAN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; SIALIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANTIBODY AFFINITY; APOPTOSIS; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; MONOCYTE; PHAGOCYTOSIS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SECONDARY NECROTIC CELL; SIALYLATION; SYSTEMIC LUPUS ERYTHEMATOSUS; VERY ELDERLY; YOUNG ADULT; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETICS; GLYCOSYLATION; IMMUNOLOGY; METABOLISM; NEUTROPHIL; PATHOLOGY; PRIMARY CELL CULTURE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; AUTOANTIBODIES; CASE-CONTROL STUDIES; GENE EXPRESSION REGULATION; GLYCOSYLATION; HISTONES; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NEUTROPHILS; PHAGOCYTOSIS; PRIMARY CELL CULTURE; SIALIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84960221908     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12744     Document Type: Article

References (23)

1. Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006; 313:670-3.
2. Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008; 320:373-6.
3. Nimmerjahn F, Anthony RM, Ravetch JV. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci USA 2007; 104:8433-7.
4. Barb AW, Brady EK, Prestegard JH. Branch-specific sialylation of IgG-Fc glycans by ST6Gal-I. Biochemistry 2009; 48:9705-7.
5. Stadlmann J, Pabst M, Altmann F. Analytical and functional aspects of antibody sialylation. J Clin Immunol 2010; 30:S15-9.
6. Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29:288-91.
7. Baumann I, Kolowos W, Voll RE et al. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46:191-201.
8. Bilyy RO, Shkandina T, Tomin A et al. Macrophages discriminate glycosylation patterns of apoptotic cell-derived microparticles. J Biol Chem 2012; 287:496-503.
9. Zirngibl M, Furnrohr BG, Janko C et al. Loading of nuclear autoantigens prototypically recognized by systemic lupus erythematosus sera into late apoptotic vesicles requires intact microtubules and myosin light chain kinase activity. Clin Exp Immunol 2015; 179:39-49.
10. Munoz LE, Janko C, Grossmayer GE et al. Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus. Arthritis Rheum 2009; 60:1733-42.
11. Munoz LE, Janko C, Chaurio RA, Schett G, Gaipl US, Herrmann M. IgG opsonized nuclear remnants from dead cells cause systemic inflammation in SLE. Autoimmunity 2010; 43:232-5.]
12. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010; 6:280-9.
13. Gullstrand B, Lefort MH, Tyden H et al. Combination of autoantibodies against different histone proteins influences complement-dependent phagocytosis of necrotic cell material by polymorphonuclear leukocytes in systemic lupus erythematosus. J Rheumatol 2012; 39:1619-27.
14. Fickentscher C, Magorivska I, Janko C et al. The pathogenicity of anti-beta2GP1-IgG autoantibodies depends on Fc glycosylation. J Immunol Res 2015; 2015:638129
15. Sjowall C, Zapf J, von Lohneysen S et al. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus. Lupus 2015; 24:569-81.
16. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci USA 2008; 105:15005-9.
17. Magorivska IB, Bilyy RO, Havrylyuk AM, Chop'yak VV, Stoika RS, Kit YY. Anti-histone H1 IgGs from blood serum of systemic lupus erythematosus patients are capable of hydrolyzing histone H1 and myelin basic protein. J Mol Recognit 2010; 23:495-502.
18. Janko C, Schorn C, Weidner D et al. Treatment with DNAse I fosters binding to nec PBMC of CRP. Autoimmunity 2009; 42:286-8.
19. Janko C, Franz S, Munoz LE et al. CRP/anti-CRP antibodies assembly on the surfaces of cell remnants switches their phagocytic clearance toward inflammation. Front Immunol 2011; 2:70
20. Bottcher A, Gaipl US, Furnrohr BG et al. Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. Arthritis Rheum 2006; 54:927-38.
21. Nimmerjahn F, Ravetch JV. The antiinflammatory activity of IgG: the intravenous IgG paradox. J Exp Med 2007; 204:11-5.
22. Mjelle JE, Kalaaji M, Rekvig OP. Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZB×NZW)F1 mice. Autoimmunity 2009; 42:104-11.
23. Sjowall C, Zickert A, Skogh T, Wettero J, Gunnarsson I. Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis. Arthritis Res Ther 2009; 11:R188.